Endemic Mycoses and COVID-19: a Review
Purpose of Review SARS-CoV-2 generates an atypical pneumonia with high morbidity and mortality. In many cases, the torpid evolution was related to bacterial or fungal co-infections. Non-specific manifestations of COVID-19 infection can make the differential diagnosis with other systemic diseases eve...
Gespeichert in:
Veröffentlicht in: | Current fungal infection reports 2022-09, Vol.16 (3), p.98-106 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose of Review
SARS-CoV-2 generates an atypical pneumonia with high morbidity and mortality. In many cases, the torpid evolution was related to bacterial or fungal co-infections. Non-specific manifestations of COVID-19 infection can make the differential diagnosis with other systemic diseases even more difficult. A review of systemic endemic mycoses associated with COVID-19 was carried out. We will describe epidemiological data, clinical characteristics of the endemic mycosis, and different diagnostic resources.
Recent Findings
Database search process in PubMed, Latindex, and other online web was performed. From 78 published cases, coccidioidomycosis was the most frequent association followed in second place by histoplasmosis. Highly variable diagnostic methodologies were used, but all were useful.
Summary
Mortality caused by these endemic mycoses does not seem to have been modified by COVID-19. |
---|---|
ISSN: | 1936-3761 1936-377X |
DOI: | 10.1007/s12281-022-00435-z |